Zyla Life Sciences Net Income (Loss) Available to Common Stockholders, Basic
Zyla Life Sciences reported Net Income (Loss) Available to Common Stockholders, Basic of -$18.24 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2020-05-14
- Zyla Life Sciences net income (loss) available to common stockholders, basic for the quarter ending 2020-03-31 was -$18.24M.
- Zyla Life Sciences net income (loss) available to common stockholders, basic for the quarter ending 2019-09-30 was -$10.29M.
- Zyla Life Sciences net income (loss) available to common stockholders, basic for the quarter ending 2019-06-30 was -$19.64M.
- Zyla Life Sciences net income (loss) available to common stockholders, basic for the quarter ending 2018-12-31 was -$19.91M.
- Zyla Life Sciences net income (loss) available to common stockholders, basic for fiscal 2018 was -$95.45M.
- Zyla Life Sciences net income (loss) available to common stockholders, basic for fiscal 2017 was -$69.36M.
- Zyla Life Sciences net income (loss) available to common stockholders, basic for fiscal 2016 was -$90.63M.
- Zyla Life Sciences net income (loss) available to common stockholders, basic for fiscal 2015 was -$57.93M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 1 month | Net Income (Loss) Available to Common Stockholders, Basic 2 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 5 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 8 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 11 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | -$18.24M 10-Q · filed 2020-05-14 | |||||||||
| 2019-12-31 | -$46.64M 10-K · filed 2020-03-26 | |||||||||
| 2019-09-30 | -$10.29M 10-Q · filed 2019-11-14 | -$29.93M derived: sum of 2 quarters · filed 2019-11-14 | -$40.42M 10-Q · filed 2019-11-14 | |||||||
| 2019-06-30 | -$19.64M 10-Q · filed 2019-11-14 | -$30.13M 10-Q · filed 2019-08-13 | ||||||||
| 2019-03-31 | -$10.48M 10-Q · filed 2020-05-14 | |||||||||
| 2019-01-31 | $107.24M 10-Q · filed 2020-05-14 | |||||||||
| 2018-12-31 | -$19.91M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$71.14M derived: sum of 2 quarters · filed 2020-03-26 | -$83.10M derived: sum of 3 quarters · filed 2020-03-26 | -$95.45M 10-K · filed 2020-03-26 | ||||||
| 2018-09-30 | -$51.23M 10-Q · filed 2019-11-14 | -$63.19M derived: sum of 2 quarters · filed 2019-11-14 | -$75.54M 10-Q · filed 2019-11-14 | -$76.98M derived: sum of 4 quarters · filed 2019-11-14 | ||||||
| 2018-06-30 | -$11.96M 10-Q · filed 2019-11-14 | -$11.96M 10-Q · filed 2018-08-09 | -$24.32M 10-Q · filed 2018-08-09 | -$25.75M derived: sum of 3 quarters · filed 2019-11-14 | -$44.70M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-03-31 | -$12.35M 10-Q · filed 2019-11-14 | -$12.35M 10-Q · filed 2018-05-10 | -$13.79M derived: sum of 2 quarters · filed 2019-11-14 | -$32.74M derived: sum of 3 quarters · filed 2019-11-14 | -$59.22M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2017-12-31 | -$1.44M 10-K · filed 2018-03-16 | -$20.39M derived: sum of 2 quarters · filed 2018-11-19 | -$46.87M derived: sum of 3 quarters · filed 2018-11-19 | -$69.36M 10-K · filed 2019-03-29 | ||||||
| 2017-09-30 | -$18.95M 10-Q · filed 2018-11-19 | -$45.43M derived: sum of 2 quarters · filed 2018-11-19 | -$70.80M 10-Q · filed 2018-11-19 | -$49.43M derived: sum of 4 quarters · filed 2018-11-19 | ||||||
| 2017-06-30 | -$26.48M 10-Q · filed 2018-08-09 | -$51.85M 10-Q · filed 2018-08-09 | -$30.48M derived: sum of 3 quarters · filed 2018-08-09 | -$3.54M derived: sum of 4 quarters · filed 2018-08-09 | ||||||
| 2017-03-31 | -$25.37M 10-Q · filed 2018-05-10 | -$4.00M derived: sum of 2 quarters · filed 2018-05-10 | $22.93M derived: sum of 3 quarters · filed 2018-05-10 | $46.71M derived: sum of 4 quarters · filed 2018-05-10 | ||||||
| 2016-12-31 | $21.37M 10-K · filed 2018-03-16 | $48.31M derived: sum of 2 quarters · filed 2018-03-16 | $72.08M derived: sum of 3 quarters · filed 2018-03-16 | -$90.63M 10-K · filed 2018-03-16 | ||||||
| 2016-09-30 | $26.94M 10-K · filed 2018-03-16 | -$26.94M 10-Q · filed 2016-11-08 | $50.71M derived: sum of 2 quarters · filed 2018-03-16 | -$69.26M 10-Q · filed 2017-11-08 | $76.05M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2016-06-30 | $23.78M 10-K · filed 2018-03-16 | -$23.78M 10-Q · filed 2016-08-05 | -$42.33M 10-Q · filed 2017-08-09 | $49.11M derived: sum of 3 quarters · filed 2018-03-16 | $66.47M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2016-03-31 | $18.55M 10-K · filed 2018-03-16 | -$18.55M 10-Q · filed 2016-05-10 | $25.34M derived: sum of 2 quarters · filed 2018-03-16 | $42.69M derived: sum of 3 quarters · filed 2018-03-16 | $59.76M derived: sum of 4 quarters · filed 2018-03-16 | |||||
| 2015-12-31 | $6.79M 10-K · filed 2017-03-13 | $24.15M derived: sum of 2 quarters · filed 2017-03-13 | $41.21M derived: sum of 3 quarters · filed 2017-03-13 | -$57.93M 10-K · filed 2018-03-16 | ||||||
| 2015-09-30 | $17.36M 10-K · filed 2017-03-13 | -$17.36M 10-Q · filed 2015-11-06 | $34.42M derived: sum of 2 quarters · filed 2017-03-13 | -$51.17M 10-Q · filed 2016-11-08 | $59.61M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2015-06-30 | $17.07M 10-K · filed 2017-03-13 | -$17.07M 10-Q · filed 2015-08-07 | -$33.81M 10-Q · filed 2016-08-05 | $42.25M derived: sum of 3 quarters · filed 2017-03-13 | $52.43M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2015-03-31 | $16.72M 10-K · filed 2017-03-13 | -$16.72M 10-Q · filed 2015-05-08 | $25.19M derived: sum of 2 quarters · filed 2017-03-13 | $35.37M derived: sum of 3 quarters · filed 2017-03-13 | $47.02M derived: sum of 4 quarters · filed 2017-03-13 | |||||
| 2014-12-31 | $8.47M 10-K · filed 2016-03-11 | -$8.47M 10-K · filed 2015-03-16 | $18.64M derived: sum of 2 quarters · filed 2016-03-11 | $30.30M derived: sum of 3 quarters · filed 2016-03-11 | -$43.21M 10-K · filed 2017-03-13 | |||||
| 2014-09-30 | $10.18M 10-K · filed 2016-03-11 | -$10.18M 10-Q · filed 2014-11-14 | $21.84M derived: sum of 2 quarters · filed 2016-03-11 | -$34.75M 10-Q · filed 2015-11-06 | $25.54M derived: sum of 4 quarters · filed 2016-03-11 | |||||
| 2014-06-30 | $11.66M 10-K · filed 2016-03-11 | -$11.66M 10-Q · filed 2014-08-14 | -$24.57M 10-Q · filed 2015-08-07 | $15.37M derived: sum of 3 quarters · filed 2016-03-11 | $9.86M derived: sum of 4 quarters · filed 2016-03-11 | |||||
| 2014-03-31 | $12.92M 10-K · filed 2016-03-11 | -$12.92M 10-Q · filed 2014-06-11 | $3.71M derived: sum of 2 quarters · filed 2016-03-11 | -$1.80M derived: sum of 3 quarters · filed 2016-03-11 | -$5.50M derived: sum of 4 quarters · filed 2016-03-11 | |||||
| 2013-12-31 | -$9.21M 10-K · filed 2015-03-16 | -$14.72M derived: sum of 2 quarters · filed 2015-03-16 | -$18.41M derived: sum of 3 quarters · filed 2015-03-16 | -$20.21M 10-K · filed 2016-03-11 | ||||||
| 2013-09-30 | -$5.51M 10-K · filed 2015-03-16 | -$9.20M derived: sum of 2 quarters · filed 2015-03-16 | -$11.00M 10-Q · filed 2014-11-14 | |||||||
| 2013-06-30 | -$3.69M 10-K · filed 2015-03-16 | -$5.49M 10-Q · filed 2014-08-14 | ||||||||
| 2013-03-31 | -$1.80M 10-K · filed 2015-03-16 | |||||||||
| 2012-12-31 | -$5.40M 10-K · filed 2015-03-16 |